{"result": {"id": "a5a22109-6c26-4efb-90a2-64e9b78ccd7e", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>高脂血症<|>event<|>A medical condition characterized by elevated levels of lipids in the blood that requires comprehensive treatment\")\n##\n(\"entity\"<|>他汀类<|>organization<|>A class of cholesterol-lowering drugs including simvastatin and pravastatin\")\n##\n(\"entity\"<|>贝特类<|>organization<|>A class of triglyceride-lowering drugs including gemfibrozil and fenofibrate\")\n##\n(\"entity\"<|>天然药物类<|>organization<|>A class of natural lipid-lowering drugs with comprehensive effects\")\n##\n(\"relationship\"<|>高脂血症<|>降脂治疗<|>Lipid-lowering treatment is the primary therapy for hyperlipidemia<|>9\")\n##\n(\"relationship\"<|>他汀类<|>辛伐他汀<|>Simvastatin belongs to the statin class of drugs<|>8\")\n##\n(\"relationship\"<|>他汀类<|>普伐他汀<|>Pravastatin belongs to the statin class of drugs<|>8\")\n##\n(\"relationship\"<|>贝特类<|>吉非罗齐<|>Gemfibrozil belongs to the fibrate class of drugs<|>8\")\n##\n(\"relationship\"<|>贝特类<|>吉非贝特<|>Fenofibrate belongs to the fibrate class of drugs<|>8\")\n##\n(\"relationship\"<|>天然药物类<|>血脂康<|>Xuezhikang belongs to the natural drug class<|>8\")\n##\n(\"relationship\"<|>高脂血症<|>冠心病<|>Hyperlipidemia is a major risk factor for coronary heart disease<|>7\")\n##\n(\"relationship\"<|>高脂血症<|>心肌梗死<|>Hyperlipidemia increases the risk of myocardial infarction<|>7\")\n##\n(\"relationship\"<|>高脂血症<|>脑卒中<|>Hyperlipidemia increases the risk of stroke<|>7\")\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166134, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 454, "prompt_tokens": 3017, "total_tokens": 3471, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2496}, "prompt_cache_hit_tokens": 2496, "prompt_cache_miss_tokens": 521}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 锻炼时间；④晚饭前 园援缘~  员小时：此时进行散步（或快走）和做保健体操，是有利于自疗糖尿 病的体育疗法。\n缘）心理健康：乐观豁达。\n　　（猿）药物治疗摇圆园世纪怨园年代初，国际医学界进行了大规模 的降脂治疗研究，结果令人振奋：长期服用降脂药物不仅降低血 脂，同时也明显减少冠心病、心肌梗死、脑卒中的发生率、致残率和 死亡率。简言之，降脂治疗最根本目的是预防、延缓冠心病、脑卒 中等疾病的发生。目前，全球医生和病人对降脂治疗极其重视，观 念发生根本性变化，因此有人称降脂的年代已经到来！\n　　　如何选择理想的降脂药？当通过合理调整饮食结构，改变不  良生活习惯，加强体育锻炼后，仍不能使血脂降至理想水平时，就  必须开始药物治疗。目前调整血脂的药物很多，主要分为以下 猿 类：①他汀类，以降低胆固醇为主，如辛伐他汀（舒降之）、普伐他  汀（普拉固）等；②贝特类，以降低三酰甘油为主，如吉非罗齐（诺  衡）、吉非贝特（力平脂）等；③天然药物类，对降低胆固醇和三酰  甘油均有效，可以升高高密度脂蛋白，具有综合降脂的功效，且不  良反应小，如血脂康等。因为血脂增高是一个缓慢的过程，血脂的  调节特别是消除血脂的不良影响也同样需要一个持续作用的过  程，因此病人应根据自身的不同情况，选择降脂作用明显、不良反\n                                                     \n\n\n\n\n\t 六、高脂血症的治疗         \n应小的降脂药物。\n摇摇缘援高脂血症综合治疗措施\n（员）改变不良的生活方式摇生活要有规律，戒烟，避免暴饮暴\n食，不能过度饮酒，消除过度紧张情绪。\n　　（圆）调整饮食结构摇以低热量、低胆固醇、低脂、低糖和高纤 维素的“四低一高”的饮食结构最为合理。\n　　　员）控制摄入的总热量：尤其超重或肥胖者应减轻体重，达到 标准体重的范围内。 减轻体重的合适速度以每周 园援缘～员千克为 宜。热量摄入的限制要根据病人的年龄、工作性质、活动能力和伴 随疾病等几个方面综合考虑，一般 约源园岁者 圆缘园～猿园千卡 （员园源缘园～员圆缘源园千焦）辕天，源园～远园岁者 圆园～圆缘园千卡（愿猿远园~  员园源\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>降脂治疗<|>event<|>A medical treatment aimed at lowering lipid levels to prevent diseases like coronary heart disease and stroke\")\n##\n(\"entity\"<|>冠心病<|>event<|>A disease that can be prevented or delayed by long-term lipid-lowering treatment\")\n##\n(\"entity\"<|>心肌梗死<|>event<|>A condition whose incidence can be reduced by lipid-lowering treatment\")\n##\n(\"entity\"<|>脑卒中<|>event<|>A condition whose incidence can be reduced by lipid-lowering treatment\")\n##\n(\"entity\"<|>辛伐他汀<|>person<|>A statin drug used to lower cholesterol, also known as Simvastatin\")\n##\n(\"entity\"<|>普伐他汀<|>person<|>A statin drug used to lower cholesterol, also known as Pravastatin\")\n##\n(\"entity\"<|>吉非罗齐<|>person<|>A fibrate drug used to lower triglycerides, also known as Gemfibrozil\")\n##\n(\"entity\"<|>吉非贝特<|>person<|>A fibrate drug used to lower triglycerides, also known as Fenofibrate\")\n##\n(\"entity\"<|>血脂康<|>person<|>A natural drug class effective in lowering both cholesterol and triglycerides\")\n##\n(\"relationship\"<|>降脂治疗<|>冠心病<|>Lipid-lowering treatment can prevent or delay the onset of coronary heart disease<|>8\")\n##\n(\"relationship\"<|>降脂治疗<|>心肌梗死<|>Lipid-lowering treatment can reduce the incidence of myocardial infarction<|>8\")\n##\n(\"relationship\"<|>降脂治疗<|>脑卒中<|>Lipid-lowering treatment can reduce the incidence of stroke<|>8\")\n##\n(\"relationship\"<|>辛伐他汀<|>降脂治疗<|>Simvastatin is a drug used in lipid-lowering treatment<|>7\")\n##\n(\"relationship\"<|>普伐他汀<|>降脂治疗<|>Pravastatin is a drug used in lipid-lowering treatment<|>7\")\n##\n(\"relationship\"<|>吉非罗齐<|>降脂治疗<|>Gemfibrozil is a drug used in lipid-lowering treatment<|>7\")\n##\n(\"relationship\"<|>吉非贝特<|>降脂治疗<|>Fenofibrate is a drug used in lipid-lowering treatment<|>7\")\n##\n(\"relationship\"<|>血脂康<|>降脂治疗<|>Xuezhikang is a natural drug used in lipid-lowering treatment<|>7\")\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_d39703b0bfaba605c35052a123b4b592c664fac3db801a43bbf0766f18068fe1_v2"}